Search filters

List of works by Denis Moro-Sibilot

A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics

scientific article published on 11 September 2018

A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial

scientific article published on 18 January 2019

A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients

scientific article published on 14 October 2019

A Rare Fusion of CLIP1 and ALK in a Case of Non-Small-Cell Lung Cancer With Neuroendocrine Features

scientific article published on 11 May 2019

ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer.

scientific article published on 8 December 2017

Adequacy of CT-guided biopsies with histomolecular subtyping of pulmonary adenocarcinomas: influence of ATS/ERS/IASLC guidelines.

scientific article published on 5 August 2013

Afatinib + Cetuximab First-line in EGFR-Mutant Lung Cancer--Letter.

scientific article

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.

scientific article

An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial

scientific article published on 20 March 2012

Are ALK rearrangement variants promising predictive biomarker of ALK tyrosine kinase inhibitors efficacy?

scientific article published on 20 March 2017

Are clinical guidelines applied in routine daily practice?: a French regional survey of physicians' clinical practices in lung cancer management (EPOTRA)

scientific article published on 14 July 2011

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

scientific article published on 04 June 2018

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

scientific article published on 12 July 2007

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

scientific article published on 21 December 2015

Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study.

scientific article published on 22 January 2015

CT characteristics of resolving ground-glass opacities in a lung cancer screening programme.

scientific article published on 4 October 2009

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

scientific article published on 08 August 2011

Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France.

scientific article published on 9 February 2017

Chemotherapy effectiveness after first-line gefitinib treatment for advanced lepidic predominant adenocarcinoma (formerly advanced bronchioloalveolar carcinoma): exploratory analysis of the IFCT-0401 trial.

scientific article published on September 2012

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer.

scientific article published on 22 October 2015

Cisplatin and carboplatin-based chemotherapy in the first-line treatment of non-small cell lung cancer: Analysis from the European FRAME study

scientific article published on 03 December 2015

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program

scientific article published on 01 November 2017

Clinical research activity of the French cancer cooperative network: Overview and perspectives

scientific article

Compliance to regional recommendations for molecular analyses and management of advanced lung cancer patients

scientific article published on 12 June 2019

Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study

scientific article published on 15 March 2018

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

scientific article published on 01 December 2019

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

scientific article

Current opinions in immune checkpoint inhibitors rechallenge in solid cancers

scientific article published on 05 October 2019

Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib ⬇️

scientific article published on August 1, 2012

Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: a French study.

scientific article published in February 2012

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice.

scientific article published on 10 August 2017

Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers

scientific article published on May 2013

Endobronchial tumours in a campaign for early detection of bronchial cancer: Computed tomography versus endoscopy.

scientific article published on 6 July 2012

Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.

scientific article published on 07 December 2011

Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504

scientific article published on 17 September 2015

Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.

scientific article published on 4 December 2009

First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule

scientific article

First- and second-line therapy for advanced nonsmall cell lung cancer.

scientific article published on April 2009

First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.

scientific article published on 23 January 2017

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

scientific article published on 07 June 2019

High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study

scientific article published on 09 October 2019

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway.

scientific article published on 12 March 2012

High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.

scientific article

How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study

scientific article

Hyperprogressive disease of non-small-cell lung adenocarcinoma under immune-checkpoint inhibitors: A new response pattern to be recognized by the radiologist

scientific article published on 08 February 2019

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

scientific article published on 10 August 2017

Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer

scientific article published on 24 October 2020

Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: baseline results of an observational study (FRAME).

scientific article published on 04 October 2012

Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.

scientific article published on 19 May 2011

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.

scientific article published on 13 March 2018

Long-term survival in patients with advanced non-small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study

scientific article published on 17 December 2018

Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort

scientific article

Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives

scientific article

Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis.

scientific article

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

scientific article published on 11 February 2019

Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensus.

scientific article published on 18 December 2014

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

scientific article published on 16 January 2019

Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study.

scientific article published on 10 November 2015

Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study).

scientific article published on 27 May 2015

Operation and Chemotherapy: Prognostic Factors for Lung Cancer With One Synchronous Metastasis.

scientific article published in February 2018

Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors.

scientific article published on 9 October 2017

Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study.

scientific article published on 21 February 2015

Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer.

scientific article published on 5 August 2017

Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: A retrospective study of 300 patients ⬇️

scientific article published on July 12, 2012

Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report.

scientific article

Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.

scientific article

Personalized chemotherapy of lung cancer: What the radiologist should know.

scientific article published on 05 February 2016

Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial

scientific article published on 01 October 2019

Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer

scientific article published on 31 October 2016

Primary lung adenocarcinoma: characteristics by smoking habit and sex.

scientific article published on 4 August 2011

Professional practice and accessibility to equipment in thoracic oncology. Results of a survey in Rhônes-Alpes region (France).

scientific article published on 9 June 2011

Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.

scientific article published on 9 December 2015

Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial

scientific article published on 06 March 2020

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†.

scientific article published on 16 February 2015

Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients.

scientific article published in January 2018

Routine molecular profiling of patients with NSCLC - Authors' reply

scientific article published on 01 September 2016

Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study ⬇️

scientific article published on October 14, 2010

Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study.

scientific article

Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort

scientific article published on 13 May 2019

Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301).

scientific article published on 16 February 2015

Targeting insulin-like growth factors in the treatment of cancer ⬇️

scientific article published on September 17, 2010

Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017

scientific article published on 27 March 2019

Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report.

scientific article published on 16 September 2017

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study

scientific article published on 20 March 2019

Use of intensive care in patients with nonresectable lung cancer.

scientific article published on 15 July 2010

VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

scientific article published on 07 September 2018

[A case of mediastinal angiosarcoma]

scientific article published on 23 July 2012

[Bronchial carcinoma and intensive care]

scientific article published on 25 October 2008

[Concomitant use of nivolumab and immunosuppressants in a renal transplant patient]

scientific article published on 12 October 2019

[Early diagnosis of bronchial carcinoma after head and neck cancer]

scientific article published on 01 May 2008

[Emergency room management of patients with lung cancer and organ failure]

scientific article published on 27 June 2019

[Imaging and PET/CT of lung cancer]

scientific article published on 01 March 2008

[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer]

scientific article published on 20 September 2018

[Multidisciplinary team meetings in cancerology: setting priorities for improvement]

scientific article published on 01 October 2011

[Non-solid and part-solid pulmonary nodules on CT scanning]

scientific article published in December 2007

[Second line chemotherapy in metastatic non-small cell lung cancer]

scientific article published on 01 September 2009

[Study of aberrant methylation of TSG in saliva in case of upper-aerodigestive-tract cancer]

scientific article published on 29 August 2008

[Targeted therapies in second line treatment of metastatic non-small cell lung cancer]

scientific article published on 01 September 2009

[What choice of first-line treatment?].

scientific article

[What treatment for a patient of PS 2-3 with stage IV non-small cell lung cancer?]

scientific article published on 01 October 2007

[When to operate in metastatic non-small cell lung cancer]

scientific article published on 01 September 2009

[Which organization for the management of thoracic cancer? Results from a French survey in Rhône-Alpes region]

scientific article published on 23 December 2011

c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas

scientific article published on 24 August 2018

Paulina is supported by:

About Paulina

Help